Bertagna Francesco, Bosio Giovanni, Biasiotto Giorgio, Fisogni Simona, Bercich Luisa, Giubbini Raffaele
Nuclear Medicine Department, Spedali Civili Brescia, Brescia, Italy.
Nucl Med Rev Cent East Eur. 2010;13(1):15-7.
Neurofibromatosis type I (NF1) is an autosomal dominant multisystem disorder. Patients with NF1 are at increased risk for developing both benign and malignant tumours. We report the case of a patient with histologically documented NF1, who underwent F18-FDG-PET/CT for staging purposes. The study revealed intense uptake at multiple masses located at the thighs (the largest presented SUV max of 6.8), popliteal regions, legs, left foot, left supraclavicular region, and at the thoracic wall between the 11th and 12th right ribs. The surgical biopsy of the largest popliteal lesion with higher uptake at F18-FDG-PET/CT documented the presence of a malignant schwannoma at histological examination. In conclusion, F18-FDG-PET/CT was probably able to help the discrimination between benign lesions related to known NF1 and the malignant transformed ones, and to assist clinical decision making.
I型神经纤维瘤病(NF1)是一种常染色体显性多系统疾病。NF1患者发生良性和恶性肿瘤的风险均增加。我们报告1例经组织学确诊为NF1的患者,该患者接受了F18-FDG-PET/CT检查以进行分期。研究显示,位于大腿(最大的SUV最大值为6.8)、腘窝区域、小腿、左脚、左锁骨上区域以及右侧第11和12肋骨之间胸壁的多个肿块有明显摄取。对F18-FDG-PET/CT摄取较高的最大腘窝病变进行手术活检,组织学检查证实为恶性神经鞘瘤。总之,F18-FDG-PET/CT可能有助于鉴别已知NF1相关的良性病变和恶性转化病变,并协助临床决策。